HLS Therapeutics Inc. (TSX:HLS)

HLS Therapeutics Statistics

Total Valuation

TSX:HLS has a market cap or net worth of CAD 137.60 million. The enterprise value is 189.84 million.

Market Cap	137.60M
Enterprise Value	189.84M

Important Dates

The last earnings date was Thursday, March 12, 2026.

Earnings Date	Mar 12, 2026
Ex-Dividend Date	n/a

Share Statistics

TSX:HLS has 31.27 million shares outstanding. The number of shares has decreased by -0.98% in one year.

Current Share Class	31.27M
Shares Outstanding	31.27M
Shares Change (YoY)	-0.98%
Shares Change (QoQ)	+6.28%
Owned by Insiders (%)	0.69%
Owned by Institutions (%)	0.39%
Float	19.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.81
PB Ratio	1.63
P/TBV Ratio	n/a
P/FCF Ratio	5.93
P/OCF Ratio	5.86
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.82, with an EV/FCF ratio of 8.18.

EV / Earnings	-11.14
EV / Sales	2.49
EV / EBITDA	7.82
EV / EBIT	n/a
EV / FCF	8.18

Financial Position

The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.81.

Current Ratio	1.11
Quick Ratio	0.75
Debt / Equity	0.81
Debt / EBITDA	2.81
Debt / FCF	2.94
Interest Coverage	-0.58

Financial Efficiency

Return on equity (ROE) is -18.69% and return on invested capital (ROIC) is -2.06%.

Return on Equity (ROE)	-18.69%
Return on Assets (ROA)	-1.73%
Return on Invested Capital (ROIC)	-2.06%
Return on Capital Employed (ROCE)	-3.69%
Weighted Average Cost of Capital (WACC)	9.66%
Revenue Per Employee	895,261
Profits Per Employee	-200,506
Employee Count	92
Asset Turnover	0.37
Inventory Turnover	1.84

Taxes

Income Tax	-610,148
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.84
52-Week Price Change	n/a
50-Day Moving Average	4.52
200-Day Moving Average	4.99
Relative Strength Index (RSI)	43.34
Average Volume (20 Days)	9,767

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:HLS had revenue of CAD 76.10 million and -17.04 million in losses. Loss per share was -0.54.

Revenue	76.10M
Gross Profit	54.45M
Operating Income	-5.63M
Pretax Income	-17.65M
Net Income	-17.04M
EBITDA	23.57M
EBIT	-5.63M
Loss Per Share	-0.54

Balance Sheet

The company has 16.07 million in cash and 68.31 million in debt, with a net cash position of -52.24 million or -1.67 per share.

Cash & Cash Equivalents	16.07M
Total Debt	68.31M
Net Cash	-52.24M
Net Cash Per Share	-1.67
Equity (Book Value)	84.56M
Book Value Per Share	2.70
Working Capital	4.08M

Cash Flow

In the last 12 months, operating cash flow was 23.49 million and capital expenditures -281,080, giving a free cash flow of 23.21 million.

Operating Cash Flow	23.49M
Capital Expenditures	-281,080
Depreciation & Amortization	29.24M
Net Borrowing	-25.22M
Free Cash Flow	23.21M
FCF Per Share	0.74

Margins

Gross margin is 71.55%, with operating and profit margins of -7.40% and -22.40%.

Gross Margin	71.55%
Operating Margin	-7.40%
Pretax Margin	-23.20%
Profit Margin	-22.40%
EBITDA Margin	30.98%
EBIT Margin	-7.40%
FCF Margin	30.50%

Dividends & Yields

TSX:HLS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.98%
Shareholder Yield	0.98%
Earnings Yield	-12.39%
FCF Yield	16.86%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSX:HLS has an Altman Z-Score of -0.89 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.89
Piotroski F-Score	4